 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Aug 15, 2015 |
| Title |
Preserved DNA Damage Checkpoint Pathway Protects From Complications in Long-standing Type 1 Diabetes |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
Gene expression analyses of fibroblasts obtained from healthy controls, Medalist -C patients and Medalist +C patients.
Type 1diabetes (T1D) is associated with late complications, mechanisms underscoring which are poorly understood. We report the derivation of induced pluripotent stem cells (iPSCs) from patients with longstanding T1D (disease duration ≥ 50years) with severe (designated Medalist +C) or absent to mild complications (designated Medalist -C). Disease modeling of iPSCs revealed impairment in growth, reprogramming and differentiation in Medalist +C. Further investigations using genomics and proteomics analyses suggested differential regulation of DNA damage checkpoint proteins favoring protection from cellular apoptosis in Medalist –C. In silico analyses revealed altered expression patterns of DNA damage checkpoint factors among the Medalist groups to be targets of miR200, whose expression was significantly elevated in Medalist +C serum. Notably, neurons differentiated from Medalist +C iPSCs showed enhanced susceptibility to genotoxic stress that worsened upon miR200 over-expression. Furthermore, knockdown of miR200 in Medalist +C fibroblasts and iPSCs rescued checkpoint protein expression and reduced DNA damage response. In summary, we report miR200 regulated DNA damage checkpoint pathway as a potential target for therapeutic intervention for treating complications of diabetes.
Clinical Characteristics of 50 year Medalist Type 1 Diabetes (T1D) patients
Medalist –C: 0/6 with CVD, 5/6 have DN Class 0-IIA, and 6/6 have no to mild NPDR.
Medalist +C: 6/6 with CVD, 5/6 have DN Class IIB or IV, and 4/6 have PDR.
CVD: cardiovascular disease; DN class: diabetic nephropathy class,
PDR: proliferative diabetic retinopathy; NPDR: non proliferative diabetic retinopathy
|
| |
|
| Overall design |
Total RNA was isolated from healthy controls, Medalist -C and Medalist+C fibroblasts in 5.6mM glucose at 24h
|
| |
|
| Contributor(s) |
Gupta MK, Kulkarni RN |
| Citation(s) |
26244933 |
| |
| Submission date |
Jul 10, 2015 |
| Last update date |
Jan 28, 2016 |
| Contact name |
Rohit N Kulkarni |
| E-mail(s) |
rohit.kulkarni@joslin.harvard.edu
|
| Phone |
6173094628
|
| Organization name |
Joslin Diabetes Center
|
| Street address |
One Joslin Place
|
| City |
Boston |
| State/province |
MA |
| ZIP/Postal code |
02120 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL10904 |
Illumina HumanHT-12 V4.0 expression beadchip (gene symbol) |
|
| Samples (24)
|
|
| Relations |
| BioProject |
PRJNA289501 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE70752_RAW.tar |
49.5 Mb |
(http)(custom) |
TAR (of IDAT) |
| GSE70752_non_normalized.txt.gz |
16.8 Mb |
(ftp)(http) |
TXT |
| Processed data included within Sample table |
|
|
|
|
 |
Less...
More...